Abstract
This chapter focuses on one important component of organic chemistry, which is aza-indolyls. The patent discussed in this chapter is aza-indolyl derivatives for treating obesity. The assignee for the patent is Roffman-LaRoche Inc and Vernnalis Research Limited, and the utility designation under which this patent is categorized is treatment of gastrointestinal disorders. Besides these two things, the chapter also mentions reactions in complete detail for the benefit of the readers. This is followed by experimental details that describe the step-by-step process for complete procedure. Lastly, The notes shed light on the entire topics covered in this chapter. Relevant prior art US Patent references are also incorporated in the last section. Repeated abstract content
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Synthetic Organic Chemistry and Methods Reported in US Patents
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
